NOV 29, 2017 10:00 AM PST

WEBINAR: RAS Oncoproteins: Therapeutic Vulnerabilities

Sponsored by: Bio-Techne
Speaker

Abstract

DATE: November 29, 2017
TIME: 10:00 AM PST

The three human RAS genes (HRAS, KRAS and NRAS) encode four highly related RAS small GTPases (HRAS, KRAS4A, KRAS4B and NRAS). RAS proteins function as GDP-GTP regulated binary on-off switches that regulate diverse cytoplasmic signaling networks. In cancer and developmental disorders (RASopathies), mutationally activated RAS proteins drive aberrant signal transduction.  RAS proteins are also the founding members of a large superfamily of small GTPases comprised of >150 members.  Since their initial identification decades ago as drivers of human cancers, there has been intense interest and effort in targeting RAS for cancer treatment. RAS genes are the most frequently mutated oncogenes in the top three causes of cancer deaths in the US in 2016 (lung, colorectal and pancreatic cancers).  In this webinar, I will discuss the vulnerabilities of RAS that have been exploited for the development of pharmacologic inhibitors of RAS function.

Learning Objectives:

  • Understand RAS function in cytoplasmic signaling
  • Understand the  potential therapeutic role of anti-RAS therapy in Cancer

Show Resources
You May Also Like
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
APR 21, 2021 5:00 PM CEST
APR 21, 2021 5:00 PM CEST
Date: April 21, 2021 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Spatial Answers Trilogy - Spatial Answers in Immunology Immunology Researchers share their Spatial Discoveries in SARS-C...
APR 01, 2021 8:00 AM PDT
C.E. CREDITS
APR 01, 2021 8:00 AM PDT
Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
JUL 15, 2021 9:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
JUL 15, 2021 9:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Date: July 15, 2021 Time: 9:00am (PDT), 12:00pm (EDT) The Pisces workflow robust, easy-to-use, end-to-end multi-omics solution for highly multiplexed targeted Spatial RNA analysis. VeranomeB...
MAR 16, 2021 10:00 AM PDT
C.E. CREDITS
MAR 16, 2021 10:00 AM PDT
Date: March 16, 2021 Time: 10:00am (PST) Scientific progress and breakthroughs today are often too expensive for most institutions to acquire. Each year, the National Institutes of Health (N...
NOV 29, 2017 10:00 AM PST

WEBINAR: RAS Oncoproteins: Therapeutic Vulnerabilities

Sponsored by: Bio-Techne

Specialty

Cancer Research

Molecular Biology

Cell Biology

Cancer Therapeutics

Immunology

Biochemistry

Biotechnology

Cancer Diagnostics

Cell Culture

Biomarkers

Genetics

Oncology

Molecular Diagnostics

Drug Discovery

Cell Signaling / Transduction

Geography

North America60%

Europe22%

Asia9%

South America4%

Africa3%

Registration Source

Website Visitors100%

Job Title

Research Scientist16%

Student14%

Educator/Faculty12%

Scientist11%

Medical Laboratory Technician11%

Executive9%

Facility/Department Manager6%

Clinical Laboratory Scientist6%

Medical Doctor/Specialist5%

Post Doc4%

Lab Management3%

Biologist2%

Consultant1%

Organization

Academic Institution13%

Clinical Laboratory7%

Biotech Company6%

Research Institute5%

Government4%

Hospital3%

Pharmaceutical Company3%

Medical School2%

Ambulatory Care2%

Life Science Company2%

Non-Profit Organization1%

Medical Center1%

Consultant1%

Media1%

Other5%


Show Resources
Loading Comments...
Show Resources
Attendees
  • See more